E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation

被引:180
作者
Le Cam, Laurent
Linares, Laetitia K.
Paul, Conception
Julien, Eric
Lacroix, Matthieu
Hatchi, Elodie
Triboulet, Robinson
Bossis, Guillaume
Shmueli, Ayelet
Rodriguez, Manuel S.
Coux, Olivier
Sardet, Claude
机构
[1] UMII, Inst Genet Mol, CNRS, UMR5535, F-34293 Montpellier, France
[2] CNRS, FRE 2593, CRBM, F-34293 Montpellier, France
[3] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[4] CIC BIOGUNE, Proteom Unit, Derio 48160, Spain
[5] Univ Gottingen, Dept Biochem, D-37073 Gottingen, Germany
关键词
D O I
10.1016/j.cell.2006.09.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 is regulated by multiple posttranslational modifications, including Hdm2-mediated ubiquitylation that drives its proteasomal degradation. Here, we identify the p53-associated factor E4F1, a ubiquitously expressed zinc-finger protein first identified as a cellular target of the viral oncoprotein E1A, as an atypical ubiquitin E3 ligase for p53 that modulates its effector functions without promoting proteolysis. E4F1 stimulates oligo-ubiquitylation in the hinge region of p53 on lysine residues distinct from those targeted by Hdm2 and previously described to be acetylated by the acetyltransferase PCAF. E4F1 and PCAF mediate mutually exclusive posttranslational modifications of p53. E4F1-dependent Ub-p53 conjugates are associated with chromatin, and their stimulation coincides with the induction of a p53-dependent transcriptional program specifically involved in cell cycle arrest, and not apoptosis. Collectively, our data reveal that E4F1 is a key posttranslational regulator of p53, which modulates its effector functions involved in alternative cell fates: growth arrest or apoptosis.
引用
收藏
页码:775 / 788
页数:14
相关论文
共 78 条
[1]   The ubiquitin ligase HectH9 regulates transcriptional activation by myc and is essential for tumor cell proliferation [J].
Adhikary, S ;
Marinoni, F ;
Hock, A ;
Hulleman, E ;
Popov, N ;
Beier, R ;
Bernard, S ;
Quarto, M ;
Capra, M ;
Goettig, S ;
Kogel, U ;
Scheffner, M ;
Helin, K ;
Eilers, M .
CELL, 2005, 123 (03) :409-421
[2]   Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter [J].
Ahmed-Choudhury, J ;
Agathanggelou, A ;
Fenton, SL ;
Ricketts, C ;
Clark, GJ ;
Maher, ER ;
Latif, F .
CANCER RESEARCH, 2005, 65 (07) :2690-2697
[3]   p53-Mdm2 - the affair that never ends [J].
Alarcon-Vargas, D ;
Ronai, Z .
CARCINOGENESIS, 2002, 23 (04) :541-547
[4]   p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells:: p21WAF1/CIP1 repression in UV induced apoptosis [J].
Allan, LA ;
Fried, M .
ONCOGENE, 1999, 18 (39) :5403-5412
[5]   Post-translational modifications and activation of p53 by genotoxic stresses [J].
Appella, E ;
Anderson, CW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10) :2764-2772
[6]  
Aurelio ON, 1998, CANCER RES, V58, P2190
[7]   Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases [J].
Barlev, NA ;
Liu, L ;
Chehab, NH ;
Mansfield, K ;
Harris, KG ;
Halazonetis, TD ;
Berger, SL .
MOLECULAR CELL, 2001, 8 (06) :1243-1254
[8]   Post-translational modification of p53 in tumorigenesis [J].
Bode, AM ;
Dong, ZG .
NATURE REVIEWS CANCER, 2004, 4 (10) :793-805
[9]   Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation [J].
Brooks, CL ;
Gu, W .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :164-171
[10]   p53 ubiquitination: Mdm2 and beyond [J].
Brooks, CL ;
Gu, W .
MOLECULAR CELL, 2006, 21 (03) :307-315